Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Psoriasis Topic Center

Featured Article

News
Comparing the Cost-Effectiveness of Phototherapy and Biologics for Psoriasis and Atopic Dermatitis Treatment
12/21/2023
Hannah Musick
"This study is necessary to allow physicians, patients, and health systems to make informed decisions regarding cost-efficacy for a variety of treatment options," said researchers.
"This study is necessary to allow physicians, patients, and health systems to make informed decisions regarding cost-efficacy for a variety of treatment options," said researchers.
"This study is necessary to...
12/21/2023
First Report Managed Care
News
High Rates of Therapy Switching Among Patients With Psoriasis Initiating Biologics
11/06/2023
Hannah Musick
“Switching was common in psoriasis patients using biologics over 24 months, with the lowest risk of switching observed with IL-23 inhibitors,” said researchers. 
“Switching was common in psoriasis patients using biologics over 24 months, with the lowest risk of switching observed with IL-23 inhibitors,” said researchers. 
“Switching was common in...
11/06/2023
First Report Managed Care
News
Mediterranean Diet Added to Standard Therapy Holds Benefit for Patients with Psoriasis
10/13/2023
Jolynn Tumolo
A healthy lifestyle that includes maintaining a proper weight, physical activity, and good nutritional choices can positively affect the course of psoriasis, according to a study published online in Nutrients. “Dietary manipulation may not...
A healthy lifestyle that includes maintaining a proper weight, physical activity, and good nutritional choices can positively affect the course of psoriasis, according to a study published online in Nutrients. “Dietary manipulation may not...
A healthy lifestyle that...
10/13/2023
First Report Managed Care
News
AI Revolutionizing Psoriasis Severity Assessment for Precise Therapy and QoL Improvement
09/15/2023

Danielle Sposato

Danielle Sposato
A recent study in the Journal of Medical Internet Research underscores the importance of precise therapy and long-term management for improving the quality of life in psoriasis patients. The study explores the potential benefits of an...
A recent study in the Journal of Medical Internet Research underscores the importance of precise therapy and long-term management for improving the quality of life in psoriasis patients. The study explores the potential benefits of an...
A recent study in the Journal of...
09/15/2023
First Report Managed Care
News
Secukinumab Well-Tolerated in Pediatric Patients With Plaque Psoriasis
08/29/2023
Jolynn Tumolo
“Secukinumab was equally well tolerated in pediatric patients across age and bodyweight subgroups, and the overall safety profile was consistent with that of adult patients, with no new or unexpected safety signals,” said researchers.
“Secukinumab was equally well tolerated in pediatric patients across age and bodyweight subgroups, and the overall safety profile was consistent with that of adult patients, with no new or unexpected safety signals,” said researchers.
“Secukinumab was equally well...
08/29/2023
First Report Managed Care
News
Interleukin-17 Inhibitors May Improve Psoriasis Symptoms When TNF Inhibitors Do Not
06/08/2023
Jolynn Tumolo
Switching to an interleukin-17 inhibitor may improve psoriasis symptoms for patients who discontinue a tumor necrosis factor inhibitor due to a lack of response.
Switching to an interleukin-17 inhibitor may improve psoriasis symptoms for patients who discontinue a tumor necrosis factor inhibitor due to a lack of response.
Switching to an interleukin-17...
06/08/2023
First Report Managed Care
News
Global Survey Suggests Patients Have Loose Grasp of Psoriatic Disease
05/16/2023
Jolynn Tumolo
Many patients with moderate to severe psoriasis lack recognition of common manifestations and comorbidities associated with psoriatic disease, according to new research.
Many patients with moderate to severe psoriasis lack recognition of common manifestations and comorbidities associated with psoriatic disease, according to new research.
Many patients with moderate to...
05/16/2023
First Report Managed Care
News
Three-Year Drug Survival 80% for Ixekizumab in Real-World Patients With Plaque Psoriasis
04/18/2023
Jolynn Tumolo
The probability of drug withdrawal was higher among patients who had a history of treatment with other biologics, researchers found.
The probability of drug withdrawal was higher among patients who had a history of treatment with other biologics, researchers found.
The probability of drug...
04/18/2023
First Report Managed Care
News
Monoclonal Antibody Effective in Pediatric Patients With Psoriasis
03/07/2023
Jolynn Tumolo
Researchers found a biologic therapy for psoriasis was safe and effective in pediatric patients and recommended an individualized, holistic approach to treatment. 
Researchers found a biologic therapy for psoriasis was safe and effective in pediatric patients and recommended an individualized, holistic approach to treatment. 
Researchers found a biologic...
03/07/2023
First Report Managed Care
News
Real-World Safety of Treatment in Patients With Psoriasis Appears Comparable to Clinical Trial Reports
10/07/2022
Jolynn Tumolo
“These results provide evidence that the long-term safety profile of apremilast in psoriasis and psoriatic arthritis in a real-world setting is comparable to that reported in clinical trials and other real-world publications,” researchers...
“These results provide evidence that the long-term safety profile of apremilast in psoriasis and psoriatic arthritis in a real-world setting is comparable to that reported in clinical trials and other real-world publications,” researchers...
“These results provide evidence...
10/07/2022
First Report Managed Care
News
Expert Review Finds Treatment Promising for Pediatric Patients With Plaque Psoriasis
09/23/2022
Jolynn Tumolo
Study authors examined the safety and efficacy of secukinumab for treating pediatric patients with moderate to severe plaque psoriasis.
Study authors examined the safety and efficacy of secukinumab for treating pediatric patients with moderate to severe plaque psoriasis.
Study authors examined the...
09/23/2022
First Report Managed Care

Newsfeed

News
Comparing the Cost-Effectiveness of Phototherapy and Biologics for Psoriasis and Atopic Dermatitis Treatment
12/21/2023
Hannah Musick
"This study is necessary to allow physicians, patients, and health systems to make informed decisions regarding cost-efficacy for a variety of treatment options," said researchers.
"This study is necessary to allow physicians, patients, and health systems to make informed decisions regarding cost-efficacy for a variety of treatment options," said researchers.
"This study is necessary to...
12/21/2023
First Report Managed Care
News
High Rates of Therapy Switching Among Patients With Psoriasis Initiating Biologics
11/06/2023
Hannah Musick
“Switching was common in psoriasis patients using biologics over 24 months, with the lowest risk of switching observed with IL-23 inhibitors,” said researchers. 
“Switching was common in psoriasis patients using biologics over 24 months, with the lowest risk of switching observed with IL-23 inhibitors,” said researchers. 
“Switching was common in...
11/06/2023
First Report Managed Care
News
Mediterranean Diet Added to Standard Therapy Holds Benefit for Patients with Psoriasis
10/13/2023
Jolynn Tumolo
A healthy lifestyle that includes maintaining a proper weight, physical activity, and good nutritional choices can positively affect the course of psoriasis, according to a study published online in Nutrients. “Dietary manipulation may not...
A healthy lifestyle that includes maintaining a proper weight, physical activity, and good nutritional choices can positively affect the course of psoriasis, according to a study published online in Nutrients. “Dietary manipulation may not...
A healthy lifestyle that...
10/13/2023
First Report Managed Care
News
AI Revolutionizing Psoriasis Severity Assessment for Precise Therapy and QoL Improvement
09/15/2023

Danielle Sposato

Danielle Sposato
A recent study in the Journal of Medical Internet Research underscores the importance of precise therapy and long-term management for improving the quality of life in psoriasis patients. The study explores the potential benefits of an...
A recent study in the Journal of Medical Internet Research underscores the importance of precise therapy and long-term management for improving the quality of life in psoriasis patients. The study explores the potential benefits of an...
A recent study in the Journal of...
09/15/2023
First Report Managed Care
News
Secukinumab Well-Tolerated in Pediatric Patients With Plaque Psoriasis
08/29/2023
Jolynn Tumolo
“Secukinumab was equally well tolerated in pediatric patients across age and bodyweight subgroups, and the overall safety profile was consistent with that of adult patients, with no new or unexpected safety signals,” said researchers.
“Secukinumab was equally well tolerated in pediatric patients across age and bodyweight subgroups, and the overall safety profile was consistent with that of adult patients, with no new or unexpected safety signals,” said researchers.
“Secukinumab was equally well...
08/29/2023
First Report Managed Care
News
Interleukin-17 Inhibitors May Improve Psoriasis Symptoms When TNF Inhibitors Do Not
06/08/2023
Jolynn Tumolo
Switching to an interleukin-17 inhibitor may improve psoriasis symptoms for patients who discontinue a tumor necrosis factor inhibitor due to a lack of response.
Switching to an interleukin-17 inhibitor may improve psoriasis symptoms for patients who discontinue a tumor necrosis factor inhibitor due to a lack of response.
Switching to an interleukin-17...
06/08/2023
First Report Managed Care
News
Global Survey Suggests Patients Have Loose Grasp of Psoriatic Disease
05/16/2023
Jolynn Tumolo
Many patients with moderate to severe psoriasis lack recognition of common manifestations and comorbidities associated with psoriatic disease, according to new research.
Many patients with moderate to severe psoriasis lack recognition of common manifestations and comorbidities associated with psoriatic disease, according to new research.
Many patients with moderate to...
05/16/2023
First Report Managed Care
News
Three-Year Drug Survival 80% for Ixekizumab in Real-World Patients With Plaque Psoriasis
04/18/2023
Jolynn Tumolo
The probability of drug withdrawal was higher among patients who had a history of treatment with other biologics, researchers found.
The probability of drug withdrawal was higher among patients who had a history of treatment with other biologics, researchers found.
The probability of drug...
04/18/2023
First Report Managed Care
News
Monoclonal Antibody Effective in Pediatric Patients With Psoriasis
03/07/2023
Jolynn Tumolo
Researchers found a biologic therapy for psoriasis was safe and effective in pediatric patients and recommended an individualized, holistic approach to treatment. 
Researchers found a biologic therapy for psoriasis was safe and effective in pediatric patients and recommended an individualized, holistic approach to treatment. 
Researchers found a biologic...
03/07/2023
First Report Managed Care
News
Real-World Safety of Treatment in Patients With Psoriasis Appears Comparable to Clinical Trial Reports
10/07/2022
Jolynn Tumolo
“These results provide evidence that the long-term safety profile of apremilast in psoriasis and psoriatic arthritis in a real-world setting is comparable to that reported in clinical trials and other real-world publications,” researchers...
“These results provide evidence that the long-term safety profile of apremilast in psoriasis and psoriatic arthritis in a real-world setting is comparable to that reported in clinical trials and other real-world publications,” researchers...
“These results provide evidence...
10/07/2022
First Report Managed Care
News
Exploring the Mechanisms of FDA-Approved siRNA Treatments in Disease Therapy
09/20/2024
Explore the groundbreaking advancements in RNA interference (RNAi) therapeutics, with a focus on the 6 US Food and Drug Administration (FDA)-approved small interfering RNA (siRNA) treatments and how they are revolutionizing disease treatment...
Explore the groundbreaking advancements in RNA interference (RNAi) therapeutics, with a focus on the 6 US Food and Drug Administration (FDA)-approved small interfering RNA (siRNA) treatments and how they are revolutionizing disease treatment...
Explore the groundbreaking...
09/20/2024
First Report Managed Care
News
High Mortality and Impairment Rates Among Older Adults in Long-Term Acute Care Hospitals
09/20/2024
Long-term acute care hospitals (LTCHs) provide critical, multidisciplinary care for medically complex patients, but survival rates and long-term functional outcomes remain poor, according to a study published in JAMA Network Open.
Long-term acute care hospitals (LTCHs) provide critical, multidisciplinary care for medically complex patients, but survival rates and long-term functional outcomes remain poor, according to a study published in JAMA Network Open.
Long-term acute care hospitals...
09/20/2024
First Report Managed Care
News
Addressing Stigma is Essential for Increasing PrEP Uptake and Adherence in HIV Prevention Efforts
09/20/2024
Addressing stigma associated with pre-exposure prophylaxis (PrEP) is crucial for improving its uptake and adherence among eligible populations, according to study results published in Sexes.
Addressing stigma associated with pre-exposure prophylaxis (PrEP) is crucial for improving its uptake and adherence among eligible populations, according to study results published in Sexes.
Addressing stigma associated...
09/20/2024
First Report Managed Care
News
UC Davis Health Unveils Innovative Strategy to Shield Patients With COPD and Asthma From Wildfire Hazards
09/20/2024
As wildfires become an annual threat due to climate change, health systems must proactively adopt air quality-focused population health approaches to protect vulnerable patients with chronic respiratory conditions like COPD and asthma,...
As wildfires become an annual threat due to climate change, health systems must proactively adopt air quality-focused population health approaches to protect vulnerable patients with chronic respiratory conditions like COPD and asthma,...
As wildfires become an annual...
09/20/2024
First Report Managed Care
News
COVID-19 Vaccination Does Not Increase Relapse Risk in Patients With Multiple Sclerosis
09/19/2024
COVID-19 vaccination does not increase the risk of severe relapse for most patients with multiple sclerosis (MS), according to study results published in the American Journal of Neurology.
COVID-19 vaccination does not increase the risk of severe relapse for most patients with multiple sclerosis (MS), according to study results published in the American Journal of Neurology.
COVID-19 vaccination does not...
09/19/2024
First Report Managed Care
News
Obesity Significantly Increases Cancer Risk in Patients With Cardiovascular Disease
09/16/2024
Obesity is associated with an increased cancer risk in patients with cardiovascular disease (CVD), highlighting the need for targeted prevention strategies, according to study results published in the Journal of the American Heart...
Obesity is associated with an increased cancer risk in patients with cardiovascular disease (CVD), highlighting the need for targeted prevention strategies, according to study results published in the Journal of the American Heart...
Obesity is associated with an...
09/16/2024
First Report Managed Care
News
CDC Invests $400 Million to Accelerate HIV Prevention and Surveillance Efforts Nationwide
09/16/2024
The Centers for Disease Control and Prevention (CDC) has awarded $400 million in funding to boost HIV prevention and surveillance efforts across the United States, aiming to accelerate progress in reducing new infections and improving health...
The Centers for Disease Control and Prevention (CDC) has awarded $400 million in funding to boost HIV prevention and surveillance efforts across the United States, aiming to accelerate progress in reducing new infections and improving health...
The Centers for Disease Control...
09/16/2024
First Report Managed Care
News
HHS Unveils Comprehensive Healthcare Reforms to Boost Equity and Quality
09/13/2024
The US Department of Health and Human Services (HHS) has announced updates to Medicare payments and policies to improve healthcare accessibility, equity, and quality for millions of Americans, according to a press release by the HHS.
The US Department of Health and Human Services (HHS) has announced updates to Medicare payments and policies to improve healthcare accessibility, equity, and quality for millions of Americans, according to a press release by the HHS.
The US Department of Health and...
09/13/2024
First Report Managed Care
News
Challenges and Emerging Strategies in Overcoming Resistance in EGFR-Mutant NSCLC
09/10/2024
Despite promising early results, adding immunotherapy to standard chemotherapy does not significantly improve outcomes for patients with EGFR-mutant non-small cell lung cancer (NSCLC) who have progressed after initial targeted therapy,...
Despite promising early results, adding immunotherapy to standard chemotherapy does not significantly improve outcomes for patients with EGFR-mutant non-small cell lung cancer (NSCLC) who have progressed after initial targeted therapy,...
Despite promising early results,...
09/10/2024
First Report Managed Care
News
New 4F-PCC Proves Effective in Rapid Reversal of Anticoagulation for Urgent Surgery, Clinical Trial Finds
09/10/2024
An investigational 4-factor prothrombin complex concentrate (4F-PCC) is as effective and safe as an FDA-approved 4F-PCC for rapidly reversing vitamin K antagonist (VKA) anticoagulation in patients requiring urgent surgery, according to a...
An investigational 4-factor prothrombin complex concentrate (4F-PCC) is as effective and safe as an FDA-approved 4F-PCC for rapidly reversing vitamin K antagonist (VKA) anticoagulation in patients requiring urgent surgery, according to a...
An investigational 4-factor...
09/10/2024
First Report Managed Care

Advertisement

Insights

Headshot of Jeffrey Stark on a blue background underneath the PopHealth Perspectives logo.
Videos
Psoriasis Treatment Effective at Achieving Skin Clearance
07/26/2021
Maria Asimopoulos
Jeffrey Stark, MD, head of immunology medical affairs, UCB, breaks down the unique challenges patients with psoriasis face, and discusses the BE RADIANT and BE SURE studies, both of which indicated that bimekizumab was effective at achieving...
Jeffrey Stark, MD, head of immunology medical affairs, UCB, breaks down the unique challenges patients with psoriasis face, and discusses the BE RADIANT and BE SURE studies, both of which indicated that bimekizumab was effective at achieving...
Jeffrey Stark, MD, head of...
07/26/2021
First Report Managed Care
Commentary
Insights Into Selecting Biologics for Psoriasis
07/08/2019
Lawrence Green, MD, associate clinical professor of dermatology at George Washington University School of Medicine, reviews current biologic therapies available for psoriasis and shares his methods for selecting the appropriate biologic for...
Lawrence Green, MD, associate clinical professor of dermatology at George Washington University School of Medicine, reviews current biologic therapies available for psoriasis and shares his methods for selecting the appropriate biologic for...
Lawrence Green, MD, associate...
07/08/2019
First Report Managed Care
Interview
Reviewing the Recently Released Psoriasis Guidelines
03/14/2019
In this discussion, Jeffery Weinberg, MD, medical dermatologist at Mount Sinai School of Medicine, and Megan Noe, MD, MPH, dermatologist at the University of Pennsylvania, highlight the new psoriasis treatment guidelines released by NPF and...
In this discussion, Jeffery Weinberg, MD, medical dermatologist at Mount Sinai School of Medicine, and Megan Noe, MD, MPH, dermatologist at the University of Pennsylvania, highlight the new psoriasis treatment guidelines released by NPF and...
In this discussion, Jeffery...
03/14/2019
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement